The fate of BRCA1-related germline mutations in triple-negative breast tumors. - Wikidata - wikimedia - TriplyDB

The fate of BRCA1-related germline mutations in triple-negative breast tumors.

The fate of BRCA1-related germline mutations in triple-negative breast tumors.

http://www.wikidata.org/entity/Q37596828

about

Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.Melanoma cases demonstrate increased carrier frequency of phenylketonuria/hyperphenylalanemia mutations.

P2860

Q33646271-25CA7223-76AB-43BC-AF65-BDA1D3D6E144 Q52688511-1F866F24-95FB-409C-A23D-88D0D623420B

P2860

The fate of BRCA1-related germline mutations in triple-negative breast tumors.

http://www.wikidata.org/entity/Q37596828

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The fate of BRCA1-related germline mutations in triple-negative breast tumors.

@en

The fate of BRCA1-related germline mutations in triple-negative breast tumors.

@nl

type

label

The fate of BRCA1-related germline mutations in triple-negative breast tumors.

@en

The fate of BRCA1-related germline mutations in triple-negative breast tumors.

@nl

prefLabel

The fate of BRCA1-related germline mutations in triple-negative breast tumors.

@en

The fate of BRCA1-related germline mutations in triple-negative breast tumors.

@nl

P1433

Q37596828-5BC32F61-CAE4-450A-8A10-F7DC50F1EB32

P1476

Q37596828-31E118A5-FBAF-4EC5-B7D8-91BC45CF4726

P2093

Q37596828-06E1BB69-FA6E-4502-BE66-0424200C4836

Q37596828-0792449E-F1C3-453E-A166-32528BEFFADD

Q37596828-0BA4539A-5524-4EED-BEF5-F9CA2671174A

Q37596828-0C46C4B4-B11F-4B9B-98BF-D305F7CFC116

Q37596828-11502C2B-CE63-472D-9509-4E5BE4DB6409

Q37596828-1457396E-8F4C-4C98-A3E5-23A5FE697742

Q37596828-1E551DFC-3B8F-44F3-A0B4-5A025EE32316

Q37596828-220AC260-3D39-4FC4-952F-B27AE58B9C1D

Q37596828-494FD8D8-C9A9-476C-A22E-A488CEEB6FF4

Q37596828-75BD922D-C6D6-468D-BC43-921C4EA7004E

P2860

Q37596828-0F3579B2-0C09-427E-9DC2-57FB8D575781

Q37596828-34A73170-ECC9-4A89-9299-ED060724DF40

Q37596828-39BAD42A-8541-4D4F-A8A4-C73DDA79E9C8

Q37596828-3DCB150F-85AB-4D42-A8C5-A8890FB09887

Q37596828-5B193B66-DDDB-4365-9F90-57E97A883D5C

Q37596828-6013D18F-2EA1-4703-B58D-9F2025FFF824

Q37596828-6C330D93-C09E-4A84-BFA0-B720DAEA3CF9

Q37596828-759C4B32-F422-4EBC-9DFE-F36C371A08AD

Q37596828-77325A0F-E411-4B1C-A54C-1EB76B548968

Q37596828-784BD9B7-8662-4250-A3D3-E807DB119F19

P304

Q37596828-CEB2E5B3-D641-43E4-B4CA-1DA980F37DAC

P31

Q37596828-57DD5162-532F-4DBD-B80C-5C6CE625086B

P433

Q37596828-A541FCB5-ECA6-4B6C-96D2-4235344C4E15

P478

Q37596828-80072404-611B-4A69-867A-662CEA0E4A99

P50

Q37596828-3382A3A8-2F5D-4C44-9955-8C647227EA43

Q37596828-52FD6A07-3BAF-4339-8E1F-9A0D7B7E48FC

Q37596828-69899D4A-B925-4BAB-AF27-583D72277A02

Q37596828-813B20A0-4EA6-43C3-B1EA-F068FBC137A9

P577

Q37596828-0A5DDB5C-33C7-4BFE-8A66-FD041D59C87B

P698

Q37596828-F260672C-8975-4B12-B53F-E3D3C0953A2E

P932

Q37596828-3165155B-29A5-4B18-BC69-4D999BA9F137

P1433

American Journal of Cancer Research

P1476

The fate of BRCA1-related germline mutations in triple-negative breast tumors.

@en

P2093

Christina Bamias

http://www.w3.org/2001/XMLSchema#string

Christos Christodoulou

http://www.w3.org/2001/XMLSchema#string

Dimitrios Bafaloukos

http://www.w3.org/2001/XMLSchema#string

Dimitrios Pectasides

http://www.w3.org/2001/XMLSchema#string

Eleftheria Tsolaki

http://www.w3.org/2001/XMLSchema#string

Evangelia Razis

http://www.w3.org/2001/XMLSchema#string

Flora Zagouri

http://www.w3.org/2001/XMLSchema#string

George Pentheroudakis

http://www.w3.org/2001/XMLSchema#string

Georgios Lazaridis

http://www.w3.org/2001/XMLSchema#string

Helen Gogas

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive molecular portraits of human breast tumours

Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes

Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel

Nonsense-mediated mRNA decay in health and disease

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation.

Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.

Mechanisms of inactivation of MLH1 in hereditary nonpolyposis colorectal carcinoma: a novel approach.

Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.

P304

98-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Drakoulis Yannoukakos

Irene Konstantopoulou

Florentia Fostira

George Fountzilas

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28123851

http://www.w3.org/2001/XMLSchema#string

P932

5250684

http://www.w3.org/2001/XMLSchema#string